Eli Lilly Moves To Toss Zyprexa Battle With Conn.

Law360, New York (June 8, 2009, 12:00 AM EDT) -- Eli Lilly and Co. has asked for summary judgment in a product liability suit over Zyprexa brought by the state of Connecticut, arguing that the state is unfairly demanding hundred of millions of dollars in refunds while continuing to recommend and promote the antipyschotic to its citizens.

The drugmaker filed a motion for summary judgment and an accompanying memorandum of law Friday in the U.S. District Court for the Eastern District of New York, contending that the state's claims about metabolic risks and off-label prescribing are...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.